Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

3.25
Delayed Data
As of 3:59pm ET
 +0.01 / +0.31%
Today’s Change
2.44
Today|||52-Week Range
10.60
-62.73%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close3.24
Today’s open3.22
Day’s range3.18 - 3.33
Volume197,126
Average volume (3 months)770,183
Market cap$171.1M
Dividend yield--
Data as of 3:59pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)+16.28%
Earnings growth (this year)-44.91%
Earnings growth (next 5 years)--
Revenue growth (last year)+170.69%
P/E ratioNM
Price/Sales21.60
Price/Book1.38

Competitors

 Today’s
change
Today’s
% change
MDWDMediwound Ltd+0.07+0.91%
INNLInnocoll Holdings PL...+0.09+1.63%
ATHXAthersys Inc-0.02-1.02%
STMLStemline Therapeutic...-0.22-2.53%
Data as of 4:00pm ET, 08/30/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$20.8M
Annual profit (last year)-$55.7M
Net profit margin-268.55%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
COO, Principal Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts

Search for Jobs